A questionnaire based study to evaluate the knowledge, attitude and perception towards pharmacovigilance among doctors in rural hospital, Jammu, India

Shallini Gupta; Kanika Khajuria; Vijay Khajuria; Niraj Kumar

doi:10.18203/2319-2003.ijbcp20184335

Authors

Shallini Gupta Department of Pharmacology, Government Medical College, Jammu, Jammu and Kashmir, India
Kanika Khajuria Department of Pharmacology, Government Medical College, Jammu, Jammu and Kashmir, India
Vijay Khajuria Department of Pharmacology, Government Medical College, Jammu, Jammu and Kashmir, India
Niraj Kumar Department of Pediatrics, Sub district Hospital, Akhnoor, Jammu. Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20184335

Keywords:

ADRs, Attitude, Knowledge, Practice, Pharmacovigilance

Abstract

Background: Monitoring and reporting of adverse drug reactions (ADRs) is very important to minimize or prevent drug caused harm. Thus, pharmacovigilance deals with it and ensures the patient safety. However, most of pharmacovigilance centers are concentrated in the urban tertiary care hospitals and contributes the maximum reports of ADRs. Participation of the rural health workers is equally important towards the success of pharmacovigilance.

Methods: The study was conducted using a pre-validated questionnaire among forty doctors in rural Sub district hospital Akhnoor, Jammu after approval of the institutional ethical committee of Government Medical Jammu. The questionnaire consisted of 16 questions (7 related to knowledge, 4 related to attitude, and 4 related to practice and one question pertained to under reporting). The responses were recorded, and data obtained was analysed and presented as number and percentage.

Results: Total 66.6% doctors gave correct response regarding the definition of pharmacovigilance and purpose of pharmacovigilance was given by 76.6% of doctors. 70% agreed that ADR reporting is a professional obligation for them. 80% responded that health care professionals are responsible for reporting ADRs. 63.3% of them were aware of a pharmacovigilance programme of India. A total of 96.6% doctors agreed that reporting of ADR is necessary and 93.3% were of the view that pharmacovigilance should be taught in detail. Majority of doctors have experienced ADRs in patients and 36.6% have seen the ADR reporting form. However, only 10% have ever reported ADR to a pharmacovigilance center. No remuneration (50%), lack of time to report ADR (30%), belief that a single unreported case may not affect ADR database (10%), and difficulty to decide whether ADR has occurred or not (10%) were important causes for under reporting of ADRs.

Conclusions: Current study has shown that majority of the doctors have good knowledge and attitude about pharmacovigilance. However, under reporting is still a major concern among rural doctors and efforts are needed to address this problem of under reporting by conducting CMEs on regular basis.

Metrics

Metrics Loading ...

References

World Health Organization. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972;498:1-25.

Kessler DA, Natanblut S, Kennedy D, Lazar E, Rheinstein P, Anello C, et al. Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993 Jun 2;269(21):2765-8.

Lee A, Thomas SHL. Adverse drug reactions. In: Walker R., Edward C, eds. Clinical Pharmacy and Therapeutics. 3rd ed. Churchill Livingstone; 2003:33-46.

Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997 Jan 22;277(4):301-6.

WHO. The importance of pharmacovigilance. World Health Organization, Geneva. 2002:146-157.

Phatak A, Nagari BG. Safety of medicines. Pharm Times. 2003;35:19-21.

Olsson S. The need for pharmacovigilance. In: Gupta SK. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House; 2001:502-508.

Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009 Dec;9(1):14.

Hazell L, Shakir SA. Under-reporting of adverse drug reactions. Drug Safety. 2006 May 1;29(5):385-96.

Moride Y, Haramburu F, Requejo AA, Begaud B. Under‐reporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997 Feb;43(2):177-81.

Kulmi M, Reddy P, Dhakre S, Shinde M, Goyal C. Knowledge, attitude and practices of pharmacovigilance among the postgraduate and undergraduate medical students in a tertiary care hospital in Central India. Int J Basic Clin Pharmacol. 2017 Apr 24;6(5):1127-32.

Upadhyaya P, Seth V, Moghe VV, Sharma M, Ahmed M. Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical college. Therapeutics Clin Risk Management. 2012;8:307.

Remesh A. Identifying the reasons for under reporting of ADR: a cross sectional survey. Res J Pharm Biol Chem Sci. 2012;3(4):1379-86.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Natural Sci Biol Med. 2013 Jan;4(1):191.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. J Pharmaceut Sci Res. 2011 Feb 1;3(2):1064.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011 Oct;2(4):129.

Chandrakapure AR, Giri SP, Khan IN, Mohammed M, Mohammed F. Pharmacovigilance: a study to evaluate knowledge, attitude, and practices of and impact of educational intervention among doctors in teaching hospital, in rural area of Jalna, India. Int J Basic Clin Pharmacol. 2017 Jan 18;4(3):427-31.

Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions. Drug Safety. 2009 Jan 1;32(1):19-31.

Muraraiah S, Rajarathna K, Sreedhar D, Basavalingu D, Jayanthi CR. A questionnaire study to assess the knowledge, attitude and practice of Pharmacovigilance in a paediatric tertiary care centre. J Chem Pharm Res. 2011;3(6):416-22.

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India. Indian J Pharmacol. 2015 Jan;47(1):65.